Russia, the first winner of the Corona virus vaccine race, has made a big claim on its first vaccine, Sputnik-V Russia says its Sputnik-V vaccine is 92% effective in protecting people from the corona virus. Russia said that according to the results of the interim trial, the Sputnik-V vaccine is 92% effective in protecting against the corona virus. The sovereign Wealth Fund made the claim on Wednesday based on the results of an interim trial of the corona vaccine.
It is worth noting here that the third phase clinical trial of Sputnik-V has been approved and is underway in various countries. The trial, conducted on 16,000 volunteers, provided 2 doses of the vaccine. The Russian Direct Investment Fund (RDIF) has informed about this. RDIF works on vaccine development and global marketing. But, experts say there is no further information about the design and protocol of the trial. It is still difficult to say anything about the results.
"Based on the data, we have an effective vaccine," said the head of RDIF. The Russian trial will continue for the next 6 months and the data of this study will be published in the International Medical Journal. Russia has so far claimed to have developed 3 vaccines for the corona virus. It launched its first vaccine Sputnik V in August . Then came the second vaccine, EpiVacCorona, on October 14, and recently Russia claimed to have developed a third vaccine against the corona virus.
No comments:
Post a Comment